Literature DB >> 22785244

Long-term survival in a dog with anaplastic oligodendroglioma treated with radiation therapy and CCNU.

Daisuke Hasegawa1, Kazuyuki Uchida, Takayuki Kuwabara, Shunta Mizoguchi, Naoko Yayoshi, Michio Fujita.   

Abstract

A 9 year-old, neutered, male French Bulldog showing cluster seizures was diagnosed with a glioma in the right piriform cortex by MRI. Hypofractionated radiation therapy (RT) was performed using a linear accelerator. Although the lesion had involuted significantly at 2 months after RT, recurrence was observed at 4 months after RT. Chemotherapy was started using CCNU (60 mg/m(2) every 6-9 weeks) and was continued for one year. Follow-up MRI revealed involution of the lesion and the intervals of CCNU were increased to every 9-14 weeks. Two years after the first presentation, the dog suffered status epilepticus, followed by deficits of left sided postural reaction with cognitive dysfunction. The dog died on day 910, and histopathological diagnosis confirmed anaplastic oligodendroglioma.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22785244     DOI: 10.1292/jvms.12-0058

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  3 in total

Review 1.  Volumetric Modulated Arc (Radio) Therapy in Pets Treatment: The "La Cittadina Fondazione" Experience.

Authors:  Mario Dolera; Luca Malfassi; Nancy Carrara; Sara Finesso; Silvia Marcarini; Giovanni Mazza; Simone Pavesi; Massimo Sala; Gaetano Urso
Journal:  Cancers (Basel)       Date:  2018-01-24       Impact factor: 6.639

2.  Survival Time after Surgical Debulking and Temozolomide Adjuvant Chemotherapy in Canine Intracranial Gliomas.

Authors:  Emma Hidalgo Crespo; Alba Farré Mariné; Martí Pumarola I Battle; Juan Francisco Borrego Massó; Alejandro Luján Feliu-Pascual
Journal:  Vet Sci       Date:  2022-08-12

3.  Anaplastic oligodendroglioma with leptomeningeal dissemination in a french bulldog.

Authors:  Yuya Nakamoto; Daisuke Fukunaga; Kazuyuki Uchida; Takashi Mori; Takuya Kishimoto; Tsuyoshi Ozawa
Journal:  J Vet Med Sci       Date:  2018-09-06       Impact factor: 1.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.